A clinical trial to compare the effects of basmisanil with a placebo in children with Dup15q syndrome
A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome
Neurodevelopmental Disorder Dup15q Syndrome
For the latest version of this information please go to www.forpatients.roche.com